Comparable biocompatibility of Phisio- and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory response

Perfusion

Volumn 25, Issue 1, 2010, Pages 9-16

  Thiara, A S ^a   Andersen, V Y ^a   Videm, V ^b   Mollnes, T E ^a,c,d   Svennevig, K ^d   Hoel, T N ^a   Fiane, A E ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c NORDLAND HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Bioline; CPB; Heparin; Inflammatory; Phisio

Indexed keywords

BIOLINE; CHEMOKINE; COMPLEMENT COMPONENT C3A; CYTOKINE; GROWTH FACTOR; HEPARIN DERIVATIVE; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; PHOSPHORYLCHOLINE; POLYPEPTIDE; SYNDECAN 1; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA CLAMPING; AORTA VALVE REPLACEMENT; ARTICLE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART DISEASE; HUMAN; HUMAN CELL; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; MATERIAL COATING; MITRAL VALVE REPLACEMENT; OPEN HEART SURGERY; OPERATION DURATION; OXYGENATOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

AGED; ANTICOAGULANTS; ANTITHROMBIN III; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT C3A; CYTOKINES; FEMALE; HEMOGLOBINS; HEPARIN; HUMANS; INFLAMMATION; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PEPTIDES; PEROXIDASE; PHOSPHORYLCHOLINE; PLATELET COUNT; SYNDECAN-1; THROMBOSIS;

EID: 77949371120     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659110362822     Document Type: Article

References (28)

1. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981 ; 304: 497-503.
2. Gu YJ, van Oeveren W., Akkerman C., Boonstra PW, Huyzen RJ, Wildevuur CRH. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993 ; 55: 917-922.
3. Redmond JM, Gillinov AM, Stuart RS, et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 1993 ; 56: 474-479.
4. Yu J., Lamba NMK, Courtney JM, et al. Polymeric biomaterials - influence of phosphorylcholine polar groups on protein adsorption and complement activation. Int J Artif Organs 1994 ; 17: 499-504.
5. De Somer F., van Belleghem Y., Foubert L., et al. In vivo evaluation of a phosphorylcholine coated cardiopulmonary bypass circuit. J Extra Corpor Technol 1999 ; 31: 62-66.
6. De Somer F., Francois K., van Oeveren W., et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg 2000 ; 18: 602-606.
7. Lewis AL, Driver M. Blending in with the body. J Chem Educ 2002 ; 79: 321-326.
8. Ishihara K., Nomura H., Mihara T., Kurita K., Iwasaki Y., Nakabayashi N. Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res 1998 ; 39: 323-330.
9. Videm V., Nilsson L., Venge P., Svennevig JL Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991 ; 15: 90-95.
10. Mollnes TE, Lea T., Froland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985 ; 22: 197-202.
11. Mollnes TE, Redl H., Hogasen K., et al. Complement activation in septic baboons detected by neoepitope-specific assays for C3B/Ic3B/C3C, C5A and the terminal C5B-9 complement complex (Tcc). Clin Exp Immunol 1993 ; 91: 295-300.
12. Thiara AP, Hoel TN, Kristiansen F., Karlsen HM, Fiane AE, Svennevig JL Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion 2007 ; 22: 323-326.
13. Pedersen TH, Videm V., Svennevig JL, et al. Extracorporeal membrane oxygenation using a centrifugal pump and a servo regulator to prevent negative inlet pressure. Ann Thorac Surg 1997 ; 63: 1333-1339.
14. Johnson D., Thomson D., Mycyk T., Burbridge B., Mayers I. Depletion of neutrophils by filter during aortocoronary bypass-surgery transiently improves postoperative cardiorespiratory status. Chest 1995 ; 107: 1253-1259.
15. Nilsson L., Kulander L., Nystrom SO, Eriksson O. Endotoxins in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990 ; 100: 777-780.
16. Moore FD, Warner KG, Assousa S., Valeri CR, Khuri SF The effects of complement activation during cardiopulmonary bypass - attenuation by hypothermia, heparin, and hemodilution. Ann Surg 1988 ; 208: 95-103.
17. Videm V., Svennevig JL, Fosse E., Semb G., Osterud A., Mollnes TE Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992 ; 103: 806-813.
18. Butler J., Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993 ; 55: 552-559.
19. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993 ; 106: 1008-1016.
20. Lappegard KT, Fung M., Bergseth G., Riesenfeld J., Mollnes TE Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition. Ann Thorac Surg 2004 ; 78: 38-44.
21. Ponath PD, Qin SX, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin - expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996 ; 97: 604-612.
22. Henry CBS, Duling BR TNF-alpha-induced permeation of the endothelial glycocalyx is mediated by proteases and free radicals. FASEB J 2000 ; 14: A686.
23. Chappell D., Jacob M., Hofmann-Kiefer K., et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. J Vasc Res 2006 ; 43: 563-564.
24. Alexopoulou AN, Multhaupt HAB, Couchman JR Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 2007 ; 39: 505-528.
25. Yang Y., MacLeod V., Miao HQ, et al. Heparanase enhances syndecan-1 shedding - a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem 2007 ; 282: 13326-13333.
26. Prondzinsky R., Knupfer A., Loppnow H., et al. Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005 ; 129: 760-766.
27. Parolari A., Camera M., Alamanni F., et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg 2007 ; 84: 823-828.
28. Johansson-Synnergren M., Nilsson F., Bengtsson A., Jeppsson A., Wiklund L. Off-pump CABG reduces complement activation but does not significantly affect peripheral endothelial function: a prospective randomized study. Scand Cardiovasc J 2004 ; 38: 53-58.